Apr-2026
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
DermaFreeze has shown interesting dynamics in its performance across various categories and states. In Arizona, the brand has maintained a relatively stable presence in the Topical category, holding the 7th rank in both January and February 2026, before slipping slightly to the 8th position in March. Notably, by April, DermaFreeze did not rank within the top 30, indicating a potential decline in market presence or increased competition. This fluctuation suggests that while DermaFreeze has a solid foothold in the Arizona market, it faces challenges that may require strategic adjustments to regain or enhance its standing.
The sales trajectory for DermaFreeze in the Topical category in Arizona also reveals some compelling insights. Despite a drop in sales from January to February, there was a rebound in March, indicating a potential recovery or successful promotional efforts during that period. However, the absence of an April ranking suggests a significant shift that could be attributed to market dynamics or internal brand strategies. This pattern highlights the importance of continuous innovation and adaptation in the competitive cannabis market, as maintaining a top position requires not only consistent quality but also agile responses to market changes.
Competitive Landscape
In the Arizona topical cannabis market, DermaFreeze has experienced fluctuating rankings and sales, reflecting a competitive landscape. While DermaFreeze maintained its position at rank 7 in January and February 2026, it slipped to rank 8 in March, and notably, it was not in the top 20 by April. This decline in rank is juxtaposed with the performance of competitors like iLava, which started at rank 5 in January, improved to rank 4 in February, but then experienced a downward trend to rank 6 by April. Meanwhile, Müv / MUV demonstrated a more stable performance, starting at rank 2 in January, dropping to rank 5 in February, and then recovering to rank 5 by April. These shifts suggest that while DermaFreeze faces challenges in maintaining its market position, there is volatility among competitors as well, indicating potential opportunities for strategic adjustments to regain rank and sales momentum.

Notable Products
In April 2026, DermaFreeze's CBD/THC 5:1 Advanced Topical Nano-Gel (500mg CBD, 100mg THC, 4oz) maintained its position as the top-performing product in the Topical category. This product has consistently held the number one rank since January 2026, showcasing its strong market presence and consumer demand. Despite a slight decrease in sales to 452 units in April, it remains the best-seller for DermaFreeze. The product's continued success highlights its dominance in the category, with no other products surpassing its performance in the past four months. Overall, DermaFreeze's product lineup shows stability, with the CBD/THC 5:1 Advanced Topical Nano-Gel leading the charge.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.







